Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc. financial statements

Sorrento Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2022

RevenueUSD 62.84MEODHD
Net income−USD 559.33MEODHD
Cash and equivalentsUSD 23.63MEODHD
Total debtUSD 134.5MEODHD

Sorrento Therapeutics, Inc. financials on 6ix · Sorrento Therapeutics, Inc. on 6ix